CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 419 enrolled
Drug / intervention
MetaNeb® Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02627742
NCT02627742N/ACompleted

Evaluation of a Practice Change to Include The MetaNeb® System to Reduce Postoperative Pulmonary Complications

Hill-Rom·interventional·Posted Dec 11, 2015·Updated Jan 29, 2024

In Brief

A clinical study evaluating MetaNeb® System for Atelectasis and Pulmonary Complications. Completed, enrolled 419 participants across 3 sites.

Detailed Summary

To determine if a therapy regimen including treatment with The MetaNeb® System had a positive impact on the rate of pulmonary complications related to atelectasis and/or secretion retention that occur in high risk post-operative patients. This is a non-randomized facility (or hospital) level pre-post intervention study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 11, 2015
Enrollment StartMar 1, 2016
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.6 years ago

Interventions

MetaNeb® Systemdevice

The treatment protocol used for Respiratory Care during the CHANGE IN PRACTICE period of the Study will be that prescribed by the patient's health care team in the routine standard care of each patient. With the exception of standard airway clearance and lung expansion procedures, other components of the patients respiratory care regimen will remain the same as during the standard therapy period, however the CHANGE IN PRACTICE will incorporate the use/treatment with The MetaNeb® System as an alternative to usual airway clearance and lung expansion procedures. Use of The MetaNeb® System will follow the labeling of the device.